David M. Hilbert
Human Genome Sciences (United States) · 90 works · 10,061 citations · h-index 30
Top works
- BLyS: Member of the Tumor Necrosis Factor Family and B Lymphocyte Stimulator
- Immune System Impairment and Hepatic Fibrosis in Mice Lacking the Dioxin-Binding Ah Receptor
- RETRACTED ARTICLE: DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL
- Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases
- Aryl-hydrocarbon Receptor-Deficient Mice Are Resistant to 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Induced Toxicity
- Attenuation of Apoptosis Underlies B Lymphocyte Stimulator Enhancement of Humoral Immune Response
- Synthesis and release of B-lymphocyte stimulator from myeloid cells
- Generation and characterization of LymphoStat‐B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator
- B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: Longitudinal observations
- Interleukin 6 is essential for in vivo development of B lineage neoplasms.
- Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: Relationships with B cell depletion, circulating antibodies, and clinical relapse
- Cutting Edge: BLyS Enables Survival of Transitional and Mature B Cells Through Distinct Mediators
- BLyS and APRIL Form Biologically Active Heterotrimers That Are Expressed in Patients with Systemic Immune-Based Rheumatic Diseases
- Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis
- Competition for BLyS-mediated signaling through Bcmd/BR3 regulates peripheral B lymphocyte numbers
- B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels
- T cell derived IL-6 is differentially required for antigen-specific antibody secretion by primary and secondary B cells.
- T cells induce terminal differentiation of transformed B cells to mature plasma cell tumors.
- In vitro culture of primary plasmacytomas requires stromal cell feeder layers.
- Multiple signaling pathways promote B lymphocyte stimulator–dependent B-cell growth and survival